ARMISTICE CAPITAL, LLC – Eagle Pharmaceuticals, Inc. Transaction History
ARMISTICE CAPITAL, LLC portfolio value:
$0
portfolio value
ARMISTICE CAPITAL, LLC quarter portfolio value change:
-40.54%
quarter
Eagle Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -100.00% | -150K shares | -6.66M | $26.42 | 0 |
Q2 2022 | share | Decrease | -33.04% | -74K shares | -4.42M | $44.43 | 150K |
Q1 2022 | share | Increase | 0.00% | 224K shares | 11.08M | $49.49 | 224K |
Q2 2021 | share | Decrease | -100.00% | -192K shares | -8.01M | $42.8 | 0 |
Q1 2021 | share | Decrease | -47.25% | -172K shares | -8.93M | $41.74 | 192K |
Q4 2020 | share | Decrease | -45.83% | -308K shares | -11.59M | $46.57 | 364K |
Q3 2020 | share | Increase | +138.30% | 390K shares | 15.01M | $42.48 | 672K |
Q2 2020 | share | Increase | 0.00% | 282K shares | 13.53M | $47.98 | 282K |